Before the FDA changed its policy on compounded meds, Lilly had been exploring ways to bring down its prices for self-pay customers, making discounted vials of Zepbound available through LillyDirect
Still, its a good potential customer acquisition strategy for Novo Nordisk, Leventhal said, because its tapping into a retailer that has a very, very loyal and large customer base. Overall, GLP-1s are getting cheaper, he added, because companies like Novo Nordisk and Eli Lilly, which makes GLP-1s Zepbound and Mounjaro, want to compete with the compounding market
Because thats not cheap, and its not an easy medication to take. What This Means For You Drugmakers are in the process of developing new oral GLP-1s that aim to be as effective or more effective as the injectables currently on the market
Orders are dispatched from EU fulfilment with tracked shipping to Dublin, Cork, Galway, Limerick and nationwide
Li S, Li Q, Li Y, et al